Emerging Viral Diagnostics (“EVDL”) 由一群經驗豐富的科學家、生物化學家和工程師組成， 共同為未被滿足的醫療需求提供解決方案。
隨著新病毒的出現對全球公共衛生構成持續威脅得到充分的證明，迅速且準確的診斷是成功控制潛在傳染病的第一步。
Emerging Viral Diagnostics (“EVDL”) 由一群經驗豐富的科學家、生物化學家和工程師組成， 共同為未被滿足的醫療需求提供解決方案。
隨著新病毒的出現對全球公共衛生構成持續威脅得到充分的證明，迅速且準確的診斷是成功控制潛在傳染病的第一步。
Under the co-operation framework agreement between the People’s Government of Pingshan District, Shenzhen, Guangdong Province, China and EVDL’s mother company Avalon BioMedical (Management) Limited, Phase 1 of this site was established in early 2021.
Manufacturing site for Cartridge production, including R&D Laboratory and Cleanroom
With the support from Hong Kong Science & Technology Parks Corporation (HKSTP), a manufacturing site including certified ISO-8 cleanroom located in MARS Centre has been established in 2022 for cartridge production.
Manufacturing site for Cartridge production, including R&D Laboratory and Cleanroom
EVDL’s R&D headquarters and is also the base of all Engineering work. Established in mid 2021 and is ISO13485:2016 (Medical Devices — Quality Management Systems) certified for device production.
Manufacturing site for Device production, also as R&D Headquarters and Engineering Workshop
